Who
Teena Lerner
Director
Company insider
Files Form 4 as: Director, Applied Therapeutics.
In numbers
- Trades disclosed
- 38
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 May 2019
- Last trade
- 3 Feb 2026
- Last filed
- 3 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Feb 2026filed 3 Feb 2026 | Applied TherapeuticsBiotechnology | SEC FORM 4 Code D | —22,500 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied TherapeuticsBiotechnology | SEC FORM 4 Code U | —82,922 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —20,460 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative | SEC FORM 4 Code D | —20,460 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative | SEC FORM 4 Code D | —10,230 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative | SEC FORM 4 Code D | —16,500 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative | SEC FORM 4 Code D | —16,500 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative | SEC FORM 4 Code D | —200,000 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative | SEC FORM 4 Code D | —23,941 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,230 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —16,500 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —16,500 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —200,000 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —23,941 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeutics | SEC FORM 4 Code D | —22,500 | filing |
| 3 Feb 2026filed 3 Feb 2026 | Applied Therapeutics | SEC FORM 4 Code U | —82,922 | filing |
| 9 Jun 2025filed 11 Jun 2025 | Applied Therapeuticsoption or derivative | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 6 Jun 2024filed 7 Jun 2024 | Applied Therapeutics | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | Applied Therapeutics | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 2 Aug 2022filed 4 Aug 2022 | Applied Therapeuticsoption or derivative | SEC FORM 4 Code D | —16,500 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.